Neonatal Abstinence Syndrome: all 68 studies

Page 1 of 1. Open to participants first (6), then studies with results posted, then the rest; newest registration first within each.

• Recorded Parent/Caregiver Voice for Infants With Neonatal Opioid Withdrawal SyndromeNot yet recruitingNCT07864493Not applicable
• An Intervention Mapping Approach to Closing the Gap in Maternal OUD and Infant NAS Care (SUPPORT)RecruitingNCT06576323Not applicable
• Study to Collect Data for Neonatal Abstinence Syndrome (NAS) and Evaluate the Automated Data Collection ProcessEnrolling by invitationNCT06303986
• MicroRNA Biomarkers for Neonatal Opioid Withdrawal SyndromeRecruitingNCT05937594
• The Alberta Neonatal Abstinence Syndrome Mother-Baby Care ImprovEmeNT ProgramRecruitingNCT05226624Not applicable
• Effect of Music Therapy on Infants With Neonatal Abstinence SyndromeRecruitingNCT03533985Not applicable
• tAN to Mitigate Withdrawal Behaviors in NeonatesCompletedNCT04588519Not applicableResults posted
• A Trial to Determine Weight Gain Benefits of Caloric Supplementation for NAS InfantsCompletedNCT04419857Not applicableResults posted
• Optimal Morphine Dosing Schedule for Neonatal Abstinence SyndromeCompletedNCT04298853Phase 4Results posted
• Medication Treatment for Opioid Use Disorder in Expectant MothersCompletedNCT03918850Phase 3Results posted
• Interventions to Help Infants Recover in the HospitalTerminatedNCT03881553Not applicableResults posted
• Clonidine as Adjunct to Morphine for Neonatal Abstinence SyndromeTerminatedNCT03762317Phase 4Results posted
• The PATH Home Trial: A Comparative Effectiveness Study of Peripartum Opioid Use Disorder in Rural KentuckyCompletedNCT03725332Not applicableResults posted
• Clonidine Versus Phenobarbital as Adjunctive Therapy for Neonatal Abstinence SyndromeCompletedNCT03670160Phase 2Results posted
• Buprenorphine Pharmacometric Open Label Research Study of Drug ExposureCompletedNCT03608696Phase 1/2Results posted
• Non-Opiate Treatment After Prenatal Opiate Exposure to Prevent Postnatal Injury to the Young BrainCompletedNCT03396588Phase 3Results posted
• Maternal Buprenorphine-naloxone Treatment and the InfantCompletedNCT03291847Phase 2Results posted
• Methadone Demonstration Project With Neonatal Intensive Care Unit Infants Diagnosed With Neonatal Abstinence SyndromeTerminatedNCT03134703Phase 2Results posted
• Weighted Blankets With Infants With NASCompletedNCT03113656Not applicableResults posted
• The Effect of Aromatherapy on Neonatal Abstinence Syndrome and Salivary Cortisol LevelsCompletedNCT03097484Phase 3Results posted
• Morphine Versus Methadone for Opiate Exposed Infants With Neonatal Abstinence SyndromeCompletedNCT02851303Phase 4Results posted
• Efficacy and Outcomes of a Non-Pharmacological Intervention for Neonatal Abstinence SyndromeCompletedNCT02801331Not applicableResults posted
• Donor Human Milk in Neonatal Abstinence SyndromeCompletedNCT02182973Results posted
• Acupuncture in Neonatal Abstinence Syndrome (NAS) BabiesCompletedNCT02062151Not applicableResults posted
• Can Ondansetron Prevent Neonatal Abstinence Syndrome (NAS) in Babies Born to Narcotic-dependent WomenCompletedNCT01965704Phase 2Results posted
• Improving Outcomes in Neonatal Abstinence SyndromeCompletedNCT01958476Phase 3Results posted
• Comparison Between Methadone and Morphine for Neonatal Opiate WithdrawalCompletedNCT01804075Phase 4Results posted
• NAS Treatment - Opiate Versus Non-OpiateCompletedNCT01734551Phase 4Results posted
• Treatment of Neonatal Abstinence SyndromeCompletedNCT01723722Phase 4Results posted
• Fetal and Infant Effects of Maternal Buprenorphine TreatmentCompletedNCT01561079Phase 2/3Results posted
• Blinded Trial of Buprenorphine or Morphine in the Treatment of the Neonatal Abstinence SyndromeCompletedNCT01452789Phase 3Results posted
• Clonidine to Treat Iatrogenic-induced Opioid Dependence in InfantsTerminatedNCT01360450Phase 2/3Results posted
• Clonidine for Neonatal Abstinence Syndrome StudyTerminatedNCT01175668Not applicableResults posted
• Neurostimulation to Improve NOWS OutcomesActive, not recruitingNCT05129020Not applicable
• Actigraphy and Neonatal Abstinence Syndrome of Hospitalized Newborn in Intensive Care UnitsStatus unknownNCT04983563Not applicable
• Effective Caregiving for Neonatal Abstinence Syndrome: Testing an Instructional Mobile Technology Platform for High-Risk Pregnant WomenActive, not recruitingNCT04783558Not applicable
• Averting NAS Among Opioid-Using Young Women Receiving MAT Using BuprenorphineStatus unknownNCT04611659Not applicable
• Clinical Trial to Decrease Length of Stay in Infants With Neonatal Abstinence Syndrome With an Exclusive Human Milk DietCompletedNCT04508348Not applicable
• Randomized Control Trial of Buprenorphine vs. Morphine for the Treatment of Neonatal Opioid Withdrawal Syndrome (NOWS)WithdrawnNCT04455802Phase 3
• Maternal Opioid Treatment: Human Experimental Research - Data Yield Appropriate DecisionsCompletedNCT04049799
• The Effect of Music Therapy on NewbornsCompletedNCT03987165Not applicable
• Actigraphy and Neonatal Abstinence SyndromeStatus unknownNCT03977545Not applicable
• Feasibility of Auricular Acupressure as an Adjunct Treatment for Neonatal Abstinence Syndrome (NAS)CompletedNCT03973801Not applicable
• Medication Treatment for Opioid Use Disorder in Expectant Mothers: Infant Neurodevelopmental Outcomes Sub-studyCompletedNCT03911739
• Medication Treatment for Opioid Use Disorder in Expectant Mothers: Conceptual Model Assessments Sub-studyCompletedNCT03911466
• Assessing the Effects of Auricular Acupressure on Newborns With NASCompletedNCT03890562Not applicable
• MOM NEST Study: Maternal Opioid Medication: Naltrexone Efficacy StudyCompletedNCT03718104
• Sound Processing Changes in Babies With Opioid ExposureCompletedNCT03567603
• Role of Low Lactose Infant Formula In The Management of Neonatal Abstinence SyndromeCompletedNCT03549936Not applicable
• Interest of Concentrations in Meconium of Buprenorphine and Methadone as a Prognostic Factor of NAS OutcomeCompletedNCT03334981
• Quantitative Assessment of Sucking for Early Diagnosis of Brain Injury in Infants at High RiskTerminatedNCT03246243
• Treatment of Neonatal Abstinence Syndrome With Clonidine Versus Morphine as Primary TherapyActive, not recruitingNCT03092011Phase 4
• Buprenorphine Dose Adjustments and Gestational AgeCompletedNCT03028883
• Efficacy of Auricular Acupuncture on Neonatal Abstinence SyndromeCompletedNCT02872077Not applicable
• How to Treat Opiate Withdrawal in NeonatesCompletedNCT02810782Phase 3
• Conflict Between Maternal Autonomy and Child Health in Substance-useCompletedNCT02797990
• Physiology and Therapeutic Management of Neonatal Abstinence SyndromeCompletedNCT02768844Not applicable
• RESPECT-PLUS: Services for Infants With Prenatal Opiate ExposureCompletedNCT02334111Not applicable
• RCT of High- vs. Standard-Calorie Formula for Methadone-Exposed InfantsCompletedNCT02178189Phase 2
• Utility of Psychosocial Intervention in Improving Outcome for Methadone-exposed Infants and Their MothersCompletedNCT01889121
• The Pharmacokinetics of Oral Methadone in the Treatment of Neonatal Abstinence SyndromeCompletedNCT01754324
• Comparison of Buprenorphine to Morphine in Treatment of Neonatal Abstinence Syndrome (NAS)CompletedNCT01708707Phase 2
• Buprenorphine for Treatment of Neonatal Abstinence Syndrome in Infants With In Utero Exposure to BenzodiazepinesCompletedNCT01671410Phase 1
• Buprenorphine for the Treatment of Neonatal Abstinence SyndromeCompletedNCT00521248Phase 1
• Clonidine as Adjunct Therapy for the Treatment of Neonatal Abstinence SyndromeCompletedNCT00510016Phase 2
• Recovery Housing For Drug Dependent Pregnant WomenCompletedNCT00497302Phase 2/3
• Tobacco Use in Opioid Agonist Treated Pregnant WomenCompletedNCT00497068Phase 2/3
• Vagal Tone and Neonatal Abstinence SyndromeCompletedNCT00496951

← Neonatal Abstinence Syndrome overview